Jury Rules Merck Patents Valid...Bad For Gilead?
March 23, 2016 at 10:58 AM EDT
Merck & Co., Inc. (NYSE: MRK) and Gilead Sciences, Inc. (NASDAQ: GILD) have been going head to head in a patent war over HCV ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.